Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
390 participants
INTERVENTIONAL
2024-09-27
2029-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome
NCT03794908
Nondrug Treatment Programs for Adults With Fibromyalgia
NCT00088777
Effects of Blue-enriched White Light Therapy in Patients with Fibromyalgia
NCT04504721
Influence of Exercise Type, Pain Mechanisms, and Biopsychosocial Contributions to Pain Relief in Those With Fibromyalgia
NCT03778385
Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects
NCT02486965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Light Therapy
All participants will be asked to attend 8 virtual visits over 5 months.
Participants randomized to the morning light therapy group are asked to wear the glasses for 1 hour per day. The timing of each person's therapy is tailored to their average wake up time during a baseline period. The treatment period is 4 weeks long.
Light Therapy
Participants will self-administer the daily light therapy within a few minutes of their assigned wake up time for one hour.
Researchers will provide a light log to note light on/off times, any interruptions to light therapy, and primary activity during light therapy.
Sleep Stabilization
All participants will be asked to attend 8 virtual visits over 5 months. Participants randomized to the sleep stabilization arm are asked to follow a fixed sleep schedule tailored to their sleep during a baseline period. The treatment period is 4 weeks.
Sleep Stabilization
All participants will be asked to follow a fixed sleep schedule.
Control Group, treatment as usual
Participants will be asked to sleep as per usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Light Therapy
Participants will self-administer the daily light therapy within a few minutes of their assigned wake up time for one hour.
Researchers will provide a light log to note light on/off times, any interruptions to light therapy, and primary activity during light therapy.
Sleep Stabilization
All participants will be asked to follow a fixed sleep schedule.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Has access to video conferencing (including web cameras and audio) and a private space for the remote study visits.
Exclusion Criteria
2. Severe hearing or memory problems
3. Pending medical leave applications at workplace
4. Current pregnancy, breastfeeding, or actively trying to get pregnant
5. Night work or travel outside the eastern time zone within 1 month of the study
6. Other research participation
7. Frequent number of special events during study period (weddings, concerts, exams, etc).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nursing Research (NINR)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helen Burgess
Professor of Psychiatry, Medical School
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Afton Hassett
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Burgess HJ, Rodgers AA, McNeil KA, Mott J, Fejer A, Dereski T, Rizvydeen M, Sibille KT, Kim HM, Cofield C, Burns JW, Shaikh S, Hassett AL. At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial. JMIR Res Protoc. 2025 Oct 13;14:e75060. doi: 10.2196/75060.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00240590
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.